Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03752268 · ClinicalTrials.gov registry record · NA
Development of an Intervention to Enhance Cancer Pain Management
A NA study, sponsored by Massachusetts General Hospital.
- Active
- Registry status
- NA
- Development phase
- 150
- Enrollment target
NCT03752268: Active NA study, sponsored by Massachusetts General Hospital.
NCT03752268 is a NA study that is active but no longer recruiting, run by Massachusetts General Hospital. The registered enrollment target is 150 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (89% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03752268, a NA study, is active but no longer recruiting, sponsored by Massachusetts General Hospital.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 150 participants
- Enrollment target
Study Summary
This research study is being done to understand how patients with chronic cancer pain take their long-acting opioid medications, and to develop an intervention to enhance cancer pain management.
Primary Outcome
Proportion of enrolled participants who complete the study, based on a criterion of greater than or equal to 75% completed sessions.
Interventions
- BEHAVIORAL Enhancing Cancer Pain Management
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2014-04-15 |
| Est. Completion | 2026-11-30 |
| Phase | NA |
What the registry record for NCT03752268 still lists
NCT03752268 is an interventional study that assigns participants to a tested intervention. The registered 150 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (89% lower).
The record links to 0 conditions, and to 1 intervention - of which Enhancing Cancer Pain Management is the first listed.
NCT03752268 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03752268 about?
NCT03752268 is a clinical study titled "Development of an Intervention to Enhance Cancer Pain Management". This research study is being done to understand how patients with chronic cancer pain take their long-acting opioid medications, and to develop an intervention to enhance cancer pain management.
What is the current status of trial NCT03752268?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 150 participants. The study started on 2014-04-15. Estimated completion is 2026-11-30.
What interventions are being tested in trial NCT03752268?
The interventions under investigation include: Enhancing Cancer Pain Management (BEHAVIORAL).
Who is sponsoring clinical trial NCT03752268?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03752268's enrollment target sits among peer trials
150 661st of 2000 higher than 1,299 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00412594 · 150 participants · Phase 2
Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia
- NCT01484730 · 150 participants
A Pilot Study to Evaluate Multi-Spectral and Laser Speckle Imaging and Multiphoton Microscopy During Vascular Occlusion
- NCT01985919 · 150 participants
Protocol for Facilitating the Acquisition of Research Bone Marrow and Blood Samples
- NCT02016248 · 150 participants · NA
SBRT Boost for Unfavorable Prostate Cancer'
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI